A National Academies of Sciences, Engineering, and Medicine committee tasked with developing an overarching framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19 will issue a discussion draft of the preliminary framework for public comment on Sept. 1.

The National Academies of Sciences, Engineering, and Medicine today released for public comment a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19.

The National Academies of Sciences, Engineering, and Medicine today released the final report of a consensus study recommending a four-phased equitable allocation framework that the U.S. Department of Health and Human Services (HHS) and state, tribal, local, and territorial (STLT) authorities should adopt in the development of national and local guidelines for COVID-19 vaccine allocation.

Decision-makers leading COVID-19 vaccine rollouts need to begin communicating with the public immediately if they have not already — emphasizing public support for vaccinations, leveraging celebrity and community champion endorsements, and focusing on those who are skeptical or hesitant of the vaccines rather than firmly opposed — to ensure demand and promote uptake, says a new rapid expert consultation from the National Academies of Sciences, Engineering, and Medicine.

The National Academy of Medicine (NAM) has established an international committee (IC) in coordination with the U.S. Department of Health and Human Services’ Office of Global Affairs (OGA) to inform and facilitate efforts to advance global influenza pandemic preparedness.

Sexually transmitted infections (STIs) impose billions of dollars in medical costs in the U.S., but STI prevention and control is chronically underfunded, stigmatized, and siloed from efforts to promote overall health and well-being, says a new report from the National Academies of Sciences, Engineering, and Medicine.

As COVID-19 vaccinations continue and accelerate across the U.S., a new rapid expert consultation from the National Academies of Sciences, Engineering, and Medicine offers advice for decision-makers communicating to the public about vaccine efficacy, effectiveness, and equity — drawing on findings from social and behavioral science.

As COVID-19 vaccination programs across the country transition from meeting urgent demand to reaching people who are less eager to get the shot, leaders are looking for new vaccine communications strategies.

As vaccination campaigns begin ramping up around the world, experts discuss how variants, misinformation, and “brain drain” are affecting pandemic-control efforts.

When communicating with parents about getting their children vaccinated against COVID-19, emphasize the safety and efficacy of the vaccines, encourage them to talk with their family doctor, and leverage parents’ social networks.

As the omicron variant of the coronavirus sweeps through the U.S. and other parts of the world — and with the possibility of emerging new variants looming — building confidence in vaccines has become even more important. How can knowledge from the social sciences inform effective communication around vaccines?

Vaccination mandates and requirements can be effective in increasing COVID-19 vaccination rates, but their success depends on being targeted and on building trust, says a new rapid expert consultation, which also outlines considerations for using incentives to promote booster uptake.

President Ahn said, "If we utilize the results of this mRNA patent analysis, it would be greatly helpful in determining the direction of future vaccine research and development."

According to a briefing by Cheong Wa Dae spokesperson Park Kyung-mee, President Moon said after hearing the news on the same day, "I highly anticipate for the first Korean vaccine to be produced and commercialized.

Phase III clinical trials

Akhane Thiphavong Offers Insight into mRNA/LNP-Based and Adenoviral COVID-19 Vaccines

Targeting two global pig diseases, and improving health and immune support in newly weaned piglets

New Peer Reviewed Science Links Increasing Incidence of Lymphatic Cancers to COVID-19 Virus as well as the mRNA Vaccines

Considering the major societal disruptions brought on by government mandates responding to the COVID19 pandemic, all communities owe their residents an objective review of the mandates imposed.

Dr. Richard Ruhling is an expert on Biblical prophecy and is also the author of 'The Alpha & Omega Bible Code'

Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke of luck, but from a repeatable process. He outlines a system called “emergent discovery” that involves working back from future ideals, pioneering in novel spaces, encouraging unreasonable ideas, and persistently questioning hypotheses. And he says this process applies to other industries besides life sciences. Afeyan is the coauthor, with HBS professor Gary Pisano, of the HBR article "What Evolution Can Teach Us About Innovation."

Moderna could seek government approval for its Covid-19 vaccine as early as November.

Smithfield Foods, the world’s largest pork processor, announced that it is actively preparing for COVID-19 vaccine distribution to employees and has medical capabilities at its U.S. plants. Meatpacking workers were among the groups hit hardest by the new coronavirus last year.

Washington, D.C. – The National Association of Broadcasters (NAB), the Donald W. Reynolds Journalism Institute (RJI) and the National Association of Chain Drug Stores (NACDS) today announced the launch of an online toolkit to help local journalists craft COVID-19 vaccine education messages that best resonate with their audiences. The toolkit is designed to provide journalists with information and resources to create news reports, public service announcements and other messages related to vaccine safety, effectiveness and distribution.

WASHINGTON, D.C. – In response to the inclusion of $1 billion for a vaccine awareness campaign in the American Rescue Plan Act of 2021, the following statement may be attributed to NAB President and CEO Gordon Smith: 

WASHINGTON, D.C. – NAB President and CEO Gordon Smith testified today before the Senate Commerce Committee's Subcommittee on Communications, Media, and Broadband at a hearing titled "Shot of Truth: Communicating Trusted Vaccine Information."

Washington, D.C. -- As founding members of the Biden Administration’s COVID-19 Community Corps, the National Association of Broadcasters (NAB) is urging all local radio and television stations to participate in a National Month of Action beginning June 4 to provide COVID-19 vaccine education and help ensure all Americans understand the importance of getting vaccinated.

Commercial Changes / Commercial viability

Commercial Changes / Commercial viability

The Ministry of Public Health is encouraging people, especially children and those in physical contact with them, to get vaccinated against whooping cough, after it started spreading in a Bangkok school.

The largest number of doses (85pc of the allocation) will go to the Democratic Republic of the Congo, the epicentre of the current outbreak.

Read more: WHO announces 899,000 mpox vaccines for nine African nations most affected

Government attorneys appealed a Texas judge's finding that the Navy's strict religious accommodation process violates the religious freedoms of 35 sailors who refused the vaccine.

The post Navy appeals court decision barring punishment for SEALs who refused vaccine first appeared on Federal News Network.

A UK-backed biotech company has achieved a pioneering biocomputer breakthrough which is accelerating the development and manufacture of cheaper drugs and vaccines.

A U.S. appeals court has declined for now to allow President Joe Biden's administration to require COVID-19 vaccinations for federal employees

The post Appeals court declines to overturn judge’s ban on federal employee vaccine mandate first appeared on Federal News Network.

Europe must back Biden in suspending patents for COVID-19 vaccines | View

Sanofi/GSK launch Phase III trial of COVID-19 vaccine, will test efficacy against variants

Location: Electronic Resource- 

The CDC says September and October are generally the best times for most people to get a COVID shot, though there are other factors to consider.